Intraday Call [12-08-2021]
Script Name Call No Buy/Sell CMP 1st Target 2nd Target Stop Loss High/Low Remark
Weekly Stock Recommendation [13-09-2021 to 17-09-2021]
Script Name Call No Buy/Sell CMP 1st Target 2nd Target Stop Loss High/Low Remark
RELIANCE W-1 Buy 2425.60 2452 2469++ 2400 - -
AXISBANK W-2 Buy 790 811 817++ 776 - -
ICICIBANK W-3 Buy 720.25 734 739++ 710 - -
ADANIGREEN W-4 Buy 1215.95 1244 1258++ 1188 - -
ANGELBRKG W-5 Buy 1228.85 1254 1267++ 1209 1284 2nd Target Hit
ADANIENT W-6 Buy 1545 1569 1582++ 1515 - Only Risk Trader
Main-line IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Paras Defence and Space Technologies Limited IPO Details 21-09-2021 23-09-2021 ₹ 170.78 Cr ₹ 175 85 ₹ 14,875 -
Sansera Engineering IPO Details 14-09-2021 16-09-2021 ₹ 1282.98 Cr ₹ 744 20 ₹ 14,880 -
Vijaya Diagnostic IPO 01-09-2021 03-09-2021 ₹ 1894.26 Cr ₹ 522 - ₹ 531 28 ₹ 14,868 Available
Ami Organics IPO 01-09-2021 03-09-2021 ₹ 569.64 Cr ₹ 603 - ₹610 24 ₹ 14,640 Available
SME IPO
Company Name Open Date Close Date Issue Size Issue Price Lot Size Mini App Allotment Status
Quadpro ITES IPO Details 20-09-2021 22-09-2021 ₹ 14.10 Cr ₹ 20 6000 ₹ 1,20,000 -
SBL Infratech Limited IPO Details 16-09-2021 20-09-2021 ₹ 2.37 Cr ₹ 111 1200 ₹ 1,33,200 -
Markolines Traffic Controls IPO Detail 15-09-2021 20-09-2021 ₹ 40.00 Cr ₹ 78 1600 ₹ 1,24,800 -
Prevest Denpro IPO Details 15-09-2021 17-09-2021 ₹ 26.61 Cr ₹ 84 1600 ₹ 1,34,400 -

Emcure Pharmaceuticals IPO Details (Upcoming IPO)


Emcure Pharmaceuticals Ltd is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lies in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood- related, oncology, respiratory, CNS & HIV among others. Emcure has launched 6 biosimilars in the Domestic Market & RoW markets & they are the domestic leader in three biologics. We are leading creation of India’s first indigenous mRNA vaccine to combat COVID- 19 which is currently under trials.

With 350+ brands, five R&D centers and 14 manufacturing facilities established across the country, we have ensured a strong foothold not just in India but also globally with a wide network across 70+ countries. Our state-of-the-art API facilities ensures that our supply chain is vertically integrated providing flexibility over control of manufacturing. We have cemented strategic global partnerships that are a result of alliances with local and multi-national companies which are at the helm of leadership in key therapeutic areas. The key objective of our widespread presence across markets is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.
Emcure Pharmaceuticals IPO Details (Update Soon)
Issue Open -
Issue Close -
Allotment Date -
Unblocked Amount -
Credit Demat Amount -
Listing Date -
Issue Size
- Total Equity Share
- Fresh Issue Equity Share
- OFS Equity Share
Issue Size ₹ - Cr
₹ - Cr Fresh
₹ - Cr OFS
IPO Price Band ₹ -
Minimum Share Bid -
Minimum Investment Amount [₹]  ₹ -
Face Value ₹ -
Qualified Institutional Buyer [QIB] - %
High Networth Individual [HNI] - %
Retail Individual Investor [RII] - %
Listing On BSE & NSE
Emcure Pharmaceuticals IPO Rating
LiveIPO -
Hem Security -
- -
- -
- -
- -
Emcure Pharmaceuticals IPO Related Link
Emcure Pharmaceuticals IPO GMP
Emcure Pharmaceuticals IPO Subscription
Emcure Pharmaceuticals IPO Allotment Status
Emcure Pharmaceuticals IPO Financial Details (₹ in Cr)
Financial Year Total Asset Total Revenue Total Expenses Profit After Tax
FY-2019 5810.439 4815.590 4469.495 202.968
FY-2020 6004.055 5130.860 4922.046 100.610
FY-2021 6807.398 6091.806 5345.885 418.594
- - - - -
Emcure Pharmaceuticals IPO Valuation Details
Earnings Per Share [EPS] ₹ 21.68
Price/Earnings [P/E] Ratio 66.12
Return on Net Worth [RoNW] 17.25 %
Net Asset Value [NAV] ₹ 125.68 Per Share
Emcure Pharmaceuticals IPO Subscription Details
As on Date QIB NII RII Total
Shared Offered - - - -
Day-1
[-]
-
[-]
-
[-]
-
[-]
-
[-]
Day-2
[-]
-
[-]
-
[-]
-
[-]
-
[-]
Day-3
[-]
-
[-]
-
[-]
-
[-]
-
[-]
Emcure Pharmaceuticals IPO Grey Market Premium
Emcure Pharmaceuticals IPO Grey Market Premium :- Click Here
Emcure Pharmaceuticals IPO Allotment Status
Emcure Pharmaceuticals IPO Allotment Status :- Click Here
 Emcure Pharmaceuticals IPO Live Subscription
Emcure Pharmaceuticals IPO Subscription in BSE:- Click Here to View
Emcure Pharmaceuticals IPO Subscription in NSE:- Click Here to View
Emcure Pharmaceuticals IPO Prospectus
Emcure Pharmaceuticals IPO DRHP
Emcure Pharmaceuticals IPO RHP (Update Soon)
Emcure Pharmaceuticals IPO Contact Details
Emcure Pharmaceuticals Ltd
Plot No. P2, IT-BT Park,
Phase II, M.I.D.C.
Hinjawadi,
Pune - 411057,
Maharashtra,
India.
Tel: +(91) 20 35070033
Contact Person: B. Renganathan,
Company Secretary and Compliance Officer; Tel: +(91) 20 66770000 / 4070 0000
Corporate Identity Number: U24231PN1981PLC024251
 Emcure Pharmaceuticals IPO Registrar
Link Intime India Private Limited
C-101, 1st Floor,
247 Park L.B.S Marg,
Vikhroli
West Mumbai 400 083
Maharashtra,
India Tel: +(91) 22 4918 6200
Investor grievance e-mail: emcurepharma.ipo@linkintime.co.in
Contact person: Shanti Gopalkrishnan
SEBI registration number: INR000004058
 Emcure Pharmaceuticals IPO Lead Managers
Axis Capital Limited
1st floor, Axis House C-2 Wadia International Centre P.B. Marg,
Worli Mumbai 400 025,
Maharashtra,
India Tel: +91 22 4325 2183
Investor Grievance ID: complaints@axiscap.in
Contact Person: Simran Gadh
SEBI Registration Number: INM000012029

BofA Securities India Limited
Ground Floor, “A” Wing One BKC,
“G” Block Bandra Kurla Complex Bandra (East),
Mumbai 400 051 Maharashtra,
India Tel: +(91) 22 6632 8000
E-mail: dg.ipo_emcure@bofa.com 
Investor Grievance E-mail: dg.india_merchantbanking@bofa.com
Contact Person: Stuti Bansal
Website: www.ml-india.com
SEBI Registration No.: INM000011625

Credit Suisse Securities (India) Private Limited
9th Floor, Ceejay House Plot F Shivsagar Estate,
Dr. Annie Besant Road Worli
Mumbai 400 018 Maharashtra,
India Tel.: + (91) 22 6777 3885
Investor Grievance E-mail: list.igcellmer-bnkg@credit-suisse.com
Contact Person: Devesh Pandey
SEBI Registration No.: INM000011161

JM Financial Limited
7th Floor, Cnergy,
Appasaheb Marathe Marg
Prabhadevi, Mumbai 400 025
Maharashtra, India
Tel.: +91 22 6630 3030
Investor grievance e-mail: grievance.ibd@jmfl.com
Contact person: Prachee Dhuri
Website: www.jmfl.com
SEBI Registration: INM000010361

BOB Capital Markets Limited
Parinee Crescenzo, 1704,
B Wing, 17th Floor Plot no.
C-38/39, G Block BKC Bandra East,
Mumbai 400 051 Maharashtra,
India Tel.: +(91) 22 6138 9300
Investor grievance e-mail: investorgrievance@bobcaps.in
Contact person: Ninad Jape/Nivedika Chavan
SEBI Registration No.: INM000009926
 Emcure Pharmaceuticals IPO FAQs
What is Emcure Pharmaceuticals IPO?
Emcure Pharmaceuticals IPO is a main-board IPO of - equity shares of the face value of ₹- aggregating up to ₹- Crores. The issue is priced at ₹- to ₹- per equity share. The minimum order quantity is - Shares.

Link-Intime India Private Ltd is the registrar for this IPO. The Emcure Pharmaceuticals IPO are to be listed on BSE NSE.

When Emcure Pharmaceuticals IPO will Open and Close?
The Emcure Pharmaceuticals IPO opens on - and closes on -.

What is Emcure Pharmaceuticals IPO Price Band?
Emcure Pharmaceuticals IPO Price Band is ₹- to ₹ - per equity share.

What is the lot size of Emcure Pharmaceuticals IPO?
Emcure Pharmaceuticals IPO the minimum bid is - Shares with ₹- amount and maximum bid is - shares with ₹-.

When Emcure Pharmaceuticals IPO Allotment date?
The Emcure Pharmaceuticals IPO Allotment will be done on -, and the allotted shares will be credited to your demat account on -.

Check the Emcure Pharmaceuticals IPO Allotment status

When is Emcure Pharmaceuticals IPO listing date?
The Emcure Pharmaceuticals IPO listing date is on -.

What is Emcure Pharmaceuticals IPO Expected Returns?
Emcure Pharmaceuticals IPO Expected Returns is -% .

How to Apply the Emcure Pharmaceuticals IPO?
You can apply Emcure Pharmaceuticals IPO using ASBA online through your internet banking.
You can also apply Emcure Pharmaceuticals IPO ASBA online via UPI ID through your stock brokers apps.
You can also apply Emcure Pharmaceuticals IPO via your stock brokers’ office by filling up the offline application form and submit to your Bank.
Disclaimer:-
       I request all investors, before applying for any IPO, please check the fundamentals and financial condition of the company and then applying to any IPO.
       www.liveipo.in will not be responsible for any kind of losses. So apply to any IPO at your risk
        We are not buying or selling any IPO forms regarding IPO Grey Market premium. We are only provide only recommendation of any IPO.
       Please do not subscribe to any IPO by just seeing the Grey Market Premium Price. It can change at any time.

0 Response to "Emcure Pharmaceuticals IPO Details (Upcoming IPO)"

Post a Comment